Enhanced peripheral blood miR-324-5p is associated with the risk of metabolic syndrome by suppressing ROCK1
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1865 (8) , 158727
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 28 references indexed in Scilit:
- In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Diabetic cardiomyopathy: mechanisms and therapeutic targetsDrug Discovery Today: Disease Mechanisms, 2010
- Excess exposure to insulin may be the primary cause of insulin resistanceAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Hepatic insulin resistance, metabolic syndrome and cardiovascular diseaseClinical Biochemistry, 2009
- CHANGES IN microRNA (miR) PROFILE AND EFFECTS OF miR‐320 IN INSULIN‐RESISTANT 3T3‐L1 ADIPOCYTESClinical and Experimental Pharmacology and Physiology, 2009
- Targeted Disruption of ROCK1 Causes Insulin Resistance in VivoJournal of Biological Chemistry, 2009
- Metabolic Syndrome PandemicArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Metabolic SyndromeCirculation, 2007
- Why Syndrome X? From Harold Himsworth to the Insulin Resistance SyndromeCell Metabolism, 2005
- The metabolic syndrome: prevalence in worldwide populationsEndocrinology and Metabolism Clinics of North America, 2004